OVERVIEW

2nd Annual Non-Opioid Pain Therapeutics Summit is organized by Hanson Wade and will be held from Jan 26 - 28, 2027 at Hyatt Regency Boston Harbor, Boston, Massachusetts, United States of America.

Description:
Uniting Global Biopharma Leaders to Accelerate the Next Generation of Non-Opioid Pain Therapeutics
One year on from Vertex Pharmaceuticals' milestone JOURNAVX® approval, making history as the first new class of pain medicine in decades, non-opioid pain R&D has skyrocketed as one of biopharma’s hottest areas for innovation and investment, projected to hit $124bn by 2034. M&A headlines, including Eli Lilly's $1bn+ acquisitions of SiteOne Therapeutics and 4E Therapeutics, AbbVie's $745m licensing deal with Haisco Pharmaceutical, continue to fuel the pain innovation flywheel.

As companies race to build on the first major clinical validation of the space, attention is rapidly expanding beyond sodium channels as a ‘silver bullet’ toward neuroimmune pathways, neurotrophin biology, GLP-1 signaling, potassium channels, gene regulation, and other emerging mechanisms.

Bringing together 150+ senior leaders across pain biology, drug discovery, translational science, clinical development, medical affairs, business development, venture capital, and patient advocacy, the 2nd Non-Opioid Pain Therapeutics Summit is the ultimate forum for drug developers to advance the next generation of pain medicines. Join experts from Vertex Pharmaceuticals, Eli Lilly, AbbVie, Grünenthal, Xenon Pharmaceuticals, Levicept, Tonix Pharma, Maxona Pharmaceuticals, 4E Therapeutics, NIH, Harvard Medical School, and leading investment firms to explore emerging mechanisms, new clinical data, trial design innovations, placebo mitigation strategies, translational models, patient-centered development approaches, and the investment trends shaping the future of pain therapeutics.

Explore the Full Event Guide

  • 30+ World Class Speakers with Cutting Edge Insights 
  • 10+ Hours of Face-to-Face Networking Opportunities 
  • 3 Days of Unmissable Data-Driven Content
  • 2 Dedicated Tracks of Workshop Content Spanning Pain Biology, Target Validation, Placebo Control, Optimized Trial Design & More for the Whole Team 
  • Scientific Poster Session & Competition

KEY DATES

Registrations Open
29 Oct, 2026
Registrations Open
Event Start Date
26 Jan, 2027
Event Start Date
Event End Date
28 Jan, 2027
Event End Date

TARGET AUDIENCE

Pain medicine

SPECIALITIES

Pain Medicine

SUGGESTED HOTELS

CONFERENCE VENUE

LocationHyatt Regency Boston Harbor
101 Harborside Dr

RELATED CONFERENCES & LIVE WEBINARS